<PAGE>
<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities and Exchange Act of 1934
(Amendment No. 1)*
Decora Industries, Inc.
- -------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 Par Value
- -------------------------------------------------------------------------------
(Title of Class of Securities)
243593100
- -------------------------------------------------------------------------------
(CUSIP Number)
Marc C. Krantz, Kohrman Jackson & Krantz,
1375 East 9th Street, Cleveland, Ohio 44114, 216-736-7204
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
December 21, 1995
- -------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with the statement [ ]. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
<PAGE> 2
<TABLE>
SCHEDULE 13D
CUSIP NO. 243593100
<S> <C>
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert W. Johnson IV
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF,SC
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- -------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 3,163,678
------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 50,000
------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 3,163,678
------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 50,000
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,213,678
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*[ ]
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.4%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
</TABLE>
<PAGE>
<PAGE> 3
CUSIP No. 243593100
This Amendment No. 1 to Schedule 13D is filed on behalf of Robert W. Johnson IV
("Johnson") for the purpose of reporting that (1) he has entered into an
Amended and Restated Note and Warrant Purchase Agreement, executed December 21,
1995 and effective as of November 3, 1995 (the "Amended Agreement"), with
Decora Industries, Inc., a Delaware corporation (the "Issuer"), and (2) in
connection with the Amended Agreement, he acquired 782,089 shares of the
Issuer's common stock, par value $0.01 per share (the "Common Stock"). Unless
otherwise defined herein, capitalized terms have the meanings ascribed to them
in the Schedule 13D filed by Johnson on November 6, 1992 (the "Johnson Schedule
13D").
Item 2. Identity and Background
Item 2 is amended and supplemented as follows:
(b) Johnson's business address is The Johnson Co., Inc., 630 Fifth
Avenue, Suite 1510, New York, New York 10111.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 is amended and supplemented as follows:
Pursuant to the terms of the Amended Agreement, Johnson and the Issuer
amended and restated the Issuer's convertible, negotiable promissory note,
dated November 3, 1992 (the "Note"), payable to Johnson in the principal amount
of $1,500,000. The maturity date of the Note was extended to May 3, 1998.
Johnson received from the Issuer 472,689 shares of Common Stock as prepaid
interest on the Note and 309,400 shares of Common Stock as consideration for
entering into the Amended Agreement. If the Note is converted into Common
Stock or prepaid in full prior to May 4, 1997, the Issuer is entitled to offset
$180,000 from the Note balance, which amount is equal to the prepaid interest
from May 4, 1997 to May 3, 1998. Otherwise, the terms of the Note are as set
forth in the Johnson Schedule 13D.
In addition, in connection with the Amended Agreement, the expiration date
of the Series A and Series B Warrants was extended to November 3, 2000, and
Johnson received from the Issuer a warrant (the "Series C Warrant") to purchase
1,700,000 shares of Common Stock for $0.78 per share. The Series C Warrant
expires on November 3, 2000.
The Series C Warrant is only exercisable if at any time the Note is paid
in full or if the Note has not been paid in full by May 3, 1998. The Series C
Warrant can not be exercised if the Note is converted into Common Stock. The
terms of the Series C Warrant are otherwise substantially identical to the
terms of the Series A and Series B Warrants, which terms are set forth in the
Johnson Schedule 13D.
<PAGE>
<PAGE> 4
CUSIP No. 243593100
Item 4. Purpose of Transaction
Item 4 is amended and supplemented as follows:
For as long as the Note remains outstanding, Johnson has the right,
pursuant to the terms of the Amended Agreement, to require that the Issuer
nominate him (or his nominee) to be elected to the Issuer's Board of Directors.
Johnson has no present plan to exercise this right.
Item 5. Interest in Securities of the Issuer
Item 5 is amended and supplemented as follows:
(a) According to the most recently available filing with the Securities
and Exchange Commission by the Issuer, there are 32,111,842 shares of Common
Stock outstanding. Johnson beneficially owns 3,213,678 shares of Common Stock
(approximately 9.4% of the sum of the 32,111,842 outstanding shares, the
472,689 shares of Common Stock received by Johnson as prepaid interest on the
Note, the 309,400 shares of Common Stock received by Johnson as consideration
for entering into the Amended Agreement, and the 1,207,353 shares of Common
Stock that may be received by Johnson upon conversion of the Note and exercise
of the Series A and Series B Warrants). Of the shares beneficially owned by
Johnson, 2,006,325 are in the form of Common Stock, 882,353 are issuable to
Johnson upon exercise of the Note, 225,000 are issuable to Johnson upon
conversion of the Series A Warrant, and 100,000 are issuable to Johnson upon
exercise of the Series B Warrant.
The 1,700,000 shares issuable to Johnson upon exercise of the Series C
Warrant are not included in the calculation of Johnson's beneficial ownership
of shares of Common Stock because under Rule 13d-3(d)(1)(i) the Series C
Warrant is not exercisable within 60 days.
Johnson disclaims beneficial interest in (i) 50,000 of the shares of
Common Stock that are held by a trust for which he is a trustee, and (ii)
135,000 shares of Common Stock that are held by trusts established by Johnson
for his children and for which he is the trustee.
(b) Johnson has sole voting and dispositive power regarding 3,163,678
shares of Common Stock.
(c) The transactions pursuant to which Johnson acquired Common Stock
described in Item 3 hereof and the Series C Warrant are the only transactions
by Johnson in the Common Stock that were affected during the past 60 days.
Item 7. Material to be Filed as Exhibits
Exhibit 7.2 hereto contains the Amended Agreement. Sections 5.03, 5.04,
5.05 and 5.06 of the Amended Agreement are the provisions regarding Johnson's
right to require that the Issuer nominate him (or his nominee) to be elected to
the Issuer's Board of Directors, as is more fully described in Item 4 herein
and in the Johnson Schedule 13D.
<PAGE>
<PAGE> 5
CUSIP No. 243593100
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Statement is true, complete and
correct.
Dated: December 28, 1995 /s/Robert W. Johnson IV
-----------------------
Robert W. Johnson IV
<PAGE>
<PAGE> 6
CUSIP No. 243593100
EXHIBIT INDEX
Exhibit 7.2 -- Amended and Restated Note and Warrant Purchase Agreement.
<PAGE>
<PAGE> 1
AMENDED AND RESTATED
NOTE AND WARRANT PURCHASE AGREEMENT
THIS AMENDED AND RESTATED NOTE AND WARRANT PURCHASE AGREEMENT (this
"Restated Agreement") is made effective as of the 3rd day of November, 1995, by
and between DECORA INDUSTRIES, INC., a Delaware corporation (the
"Corporation"), and ROBERT W. JOHNSON IV, an individual who is a resident of
the State of New York ("Purchaser").
RECITALS
A. Immediately prior to the execution of the Restated Agreement,
Purchaser owned, beneficially, 2,431,589 shares of the Corporation's common
stock, $0.01 par value per share ("Common Stock"), including shares of Common
Stock issuable upon conversion of the Existing Note (as hereinafter defined)
and the Warrants (as hereinafter defined, other than the Series C Warrant).
B. As of November 3, 1992 as reflected in a Note and Warrant Purchase
Agreement. dated as of such date (the "Purchase Agreement"), Purchaser was
issued (i) a promissory note in the principal amount of $1,500,000 that is
convertible into shares of Common Stock at the price of $1.70 per share (the
"Existing Note"), (ii) a warrant to purchase 225,000 shares of Common Stock at
the price of $1.40 per share and (iii) a Warrant to purchase 100,000 shares of
Common Stock that is exercisable as determined in such Warrant.
C. Purchaser has agreed to amend and restate the Existing Note upon the
amendment of both of the above-described warrants, issuance of an additional
warrant to purchase up to 1,700,000 shares, prepayment of interest for the
amended and restated note, and issuance of 309,400 shares of Common Stock as a
closing fee.
D. As consideration for Purchaser's entering into this Restated
Agreement and amendment and restatement of the Existing Note, the Corporation
desires to issue 309,400 shares of Common Stock to Purchaser upon execution of
this Agreement.
AGREEMENTS
In consideration of the premises and the mutual covenants herein contained
and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the parties hereto hereby agree as follows:
ARTICLE I
Amendment of the Existing Note and
Series A and Series B Warrant and Authorization
And Sale of Series C Warrant
1.01 Authorizations. Prior to the Closing, the Corporation shall (a)
authorize the issuance to Purchaser of 309,400 shares of Common Stock as
<PAGE>
<PAGE> 2
consideration for entering into this Agreement, (b) authorize the amendment and
restatement of the Existing Note in the form of the amended and restated
convertible negotiable promissory note (the "Amended Note") attached hereto as
Exhibit 1.01(b), (c) authorize the extension of the Purchaser s Warrant to
purchase 225,000 shares of Common Stock at the price of $1.40 per share (the
"Amended Series A Warrant") in the form of the amendment attached hereto as
Exhibit 1.01(c), which Amended Series A Warrant shall be entered into by
Purchaser in connection with the extension of the Existing Note, (d) authorize
the extension of the Purchaser s warrant to purchase 100,000 shares of Common
Stock exercisable as determined in such warrant (the "Amended Series B
Warrant") in the form of the amendment attached hereto as Exhibit 1.01(d),
which Amended Series B Warrant shall be entered into by Purchaser in connection
with the extension of the Existing Note, (e) authorize the issuance and sale to
Purchaser of a warrant to purchase 1,700,000 shares of Common Stock at an
initial price of $0.78 per share (the "Series C Warrant") in the form of the
warrant attached hereto as Exhibit 1.01(e) which Series C Warrant shall be
issued to Purchaser in connection with the extension of the Existing Note, (f)
authorize the issuance to Purchaser of 472,689 shares of Common Stock
representing the prepaid interest due under the Amended Note, and (g) reserve
817,647 shares of Common Stock for issuance upon exercise of the Series C
Warrant. The Series A Warrant, as amended, the Series B Warrant, as amended,
and the Series C Warrant are sometimes hereinafter collectively referred to as
the "Warrants".
1.02 Consideration for Sale; Amendment of Series A and Series B Warrants;
Sale of Series C Warrant. In reliance upon the respective representations and
warranties of the parties set forth herein and upon the certificates delivered
by the Corporation pursuant hereto, (a) the Corporation agrees to issue 309,400
shares of Common Stock to Purchaser upon Purchaser's execution of this
Agreement, and 472,689 shares of Common Stock to Purchaser representing prepaid
interest due under the Note, in each case free and clear of any liens, claims,
charges and encumbrances whatsoever, (b) the Corporation agrees to amend the
Series A and Series B Warrants and (c) the Corporation agrees to sell to
Purchaser, free and clear of any liens, claims, charges and encumbrances
whatsoever, and Purchaser agrees to purchase from the Corporation, at the
Closing, the Series C Warrant, all as consideration for Purchaser s agreement
to amend and restate the Note. Nothing herein shall constitute, or shall be
deemed to constitute, a payment, settlement or novation of the indebtedness
evidenced by the Existing Note or to release or otherwise adversely affect any
right of Purchaser against the Corporation.
ARTICLE II
Closing and Delivery
2.01 Closing. The closing of the extension of the Existing Note and
Series A and Series B Warrants and the purchase of the Series C Warrant (the
"Closing") shall take on place or before the 22nd day of December, 1995, or on
such other date as may be agreed to in writing by the parties (such date being
hereinafter referred to as the "Closing Date"), and shall be deemed to take
place in New York, New York.
<PAGE>
<PAGE> 3
2.02 Delivery. At the Closing, the Corporation shall deliver to Purchaser
(a) stock certificates for 309,400 shares and 472,689 shares, respectively, of
Common Stock, each duly executed and registered in Purchaser's name, (b) the
Amended Note, dated November 3, 1995 and duly executed, (c) the Amended Series
A and Series B Warrants which Warrants shall be duly executed and (d) the
Series C Warrant, which Warrant shall be duly executed and registered in
Purchaser's name.
ARTICLE III
Representations and Warranties
of the Corporation
The Corporation hereby makes the following representations and warranties
to Purchaser:
3.01 Corporate Existence. Each of the Corporation and Decora,
Incorporated ("Decora Manufacturing") is a corporation duly organized and in
good standing under the laws of the jurisdiction of its incorporation and is
duly qualified to do business and is in good standing in each jurisdiction
where the character of its assets or the nature of its activities requires such
qualification.
3.02 Capitalization. The Corporation's authorized capital stock consists
of 45,000,000 shares of Common Stock and 5,000,000 shares of preferred stock
("Preferred Stock"). Immediately prior to the Closing, 32,111,842 shares of
Common Stock and zero (0) shares of Preferred Stock shall be issued and
outstanding.
3.03 Corporate Power. The Corporation has all requisite corporate power
necessary to own all properties owned by it, to conduct its business as now
conducted and as proposed to be conducted by it, to enter into this Agreement,
the Amended Note, the Warrants and all other agreements, documents and
instruments contemplated hereby and thereby (sometimes collectively referred to
herein as the "Operative Documents") to which it is a party, to carry out all
transactions contemplated by the Operative Documents, and to issue the Amended
Note and the Warrants to Purchaser as provided herein.
3.04 Authorization. The Corporation and its directors and stockholders
have taken all corporate action necessary for the authorization, approval,
execution, issuance, delivery and performance of the Operative Documents to
which it is a party, the consummation of the transactions contemplated by the
Operative Documents, and the shares of Common Stock issuable upon execution of
this Agreement by Purchaser, payment of interest on the Amended Note,
conversion of the Amended Note and the exercise of the Warrants.
3.05 Binding Effect. Each of the Operative Documents to which the
Corporation is a party is the legal, valid and binding obligation of the
Corporation and is enforceable against the Corporation in accordance with its
terms, subject to any applicable bankruptcy, reorganization, insolvency,
<PAGE>
<PAGE> 4
moratorium or other similar laws or equitable principles affecting the
enforcement of creditors' rights generally, whether considered in a proceeding
at law or in equity.
3.06 Compliance with Corporate Instruments. Neither the Corporation nor
Decora Manufacturing is in violation of any provision of its certificate of
incorporation, by-laws or other governing documents.
3.07 Compliance with Laws and Regulations; Subsidiaries. The Corporation
and Decora Manufacturing is in compliance in all material respects with all
laws, orders, regulations and ordinances of all federal, state and local
governmental authorities (including, without limitation, federal and state
securities and blue sky agencies) that are applicable to it. Other than Decora
Manufacturing, the Corporation has no Subsidiaries presently engaged in active
business operations. As used in this Agreement, "Subsidiary" or "Subsidiaries"
shall mean any or all corporations, respectively, of which the Corporation
owns, directly or indirectly, more than fifty percent (50%) of the outstanding
capital stock having voting power to elect a majority of the board of directors
of such corporation.
3.08 Consents. The Corporation has obtained all consents, approvals,
qualifications, licenses, orders or authorizations of, and filings with, all
federal, state and local governmental authorities (including, without
limitation, federal and state securities and blue sky agencies) that are
required, prior to the Closing, in connection with (a) the offer, sale and
issuance of the Amended Note, the Warrants and shares of Common Stock issuable
upon execution of this Agreement by Purchaser, payment of interest on the
Amended Note, conversion of the Amended Note and the exercise of the Warrants,
(b) the valid execution, delivery and performance of the Operative Documents to
which it is a party, and (c) the consummation of any other transactions
contemplated by the Corporation or any of said Operative Documents.
3.09 Exemption from Registration. The offer, sale and issuance of the
Amended Note and the Warrants as contemplated herein and the issuance of the
Common Stock issuable upon execution of this Agreement by Purchaser, payment of
interest on the Amended Note, conversion of the Amended Note and the exercise
of the Warrants are exempt from the registration requirements of Securities Act
of 1933, as amended (the "Securities Act"), and the Corporation shall not take
any action that would cause the loss of said exemption.
3.10 Validity of Shares. The shares of Common Stock issuable upon
execution of this Agreement by Purchaser, payment of interest on the Amended
Note, conversion of the Amended Note and the exercise of the Warrants have been
duly and validly reserved and, upon issuance upon execution of this Agreement
by Purchaser, payment of interest on the Amended Note, conversion of the
Amended Note and the exercise of the Warrants, shall be duly and validly
issued, fully paid, non-assessable and free and clear of all liens, security
interests, mortgages, pledges, claims, charges and encumbrances whatsoever
(collectively, "Liens").
<PAGE>
<PAGE> 5
3.11 No Violation. The execution, delivery and performance by the
Corporation of the Operative Documents to which it is a party shall not (a)
conflict with, or result in a breach of any provision of the certificate of
incorporation, by-laws or other governing documents of the Corporation or
Decora Manufacturing, (b) result in a default, give rise to any right of
termination, cancellation or acceleration, or result in the imposition of any
Liens, or require any consent or approval, under any of the terms, conditions
or provisions of any material note, bond, mortgage, indenture, loan, license,
agreement, lease or other instrument to which the Corporation or Decora
Manufacturing is a party or by which it or they or the properties of any of
them may be bound, or (c) violate any law, judgment, order, writ, injunction,
order, rule or regulation of any federal, state or local government, court,
arbitrator, bureau, board, commission, office, authority, department or other
governmental agency applicable to the Corporation or Decora Manufacturing, the
violation of which could have a material adverse effect on the Corporation or
any of its properties or assets.
3.12 No Litigation. Except as otherwise specifically set forth in
Schedule 3.12 attached hereto, there are no actions, suits, proceedings or
investigations, pending or threatened against or affecting the Corporation or
Decora Manufacturing, whether at law or in equity, before any federal, state or
local court, arbitrator, bureau, board, commission, office, authority,
department or other governmental agency that may, if determined adversely, have
a material adverse effect on the Corporation or Decora Manufacturing or result
in a damage, claim or other liability of the Corporation or Decora
Manufacturing in excess of $25,000.
3.13 Financial Statements. The Corporation has furnished Purchaser with
its Form 10-K for its year ended March 31, 1995 and its Form 10-Q for June 30,
1995 and September 30, 1995 (the "Financial Statements"). The Financial
Statements have been prepared in accordance with generally accepted accounting
principles consistently applied, and fairly and accurately present the
financial position of the Corporation and its Subsidiaries for the periods to
which they relate.
3.14 Absence of Undisclosed Liabilities. Except as incurred in the
ordinary course of business and consistent with past practices, neither the
Corporation nor its Subsidiaries has incurred any liabilities (whether fixed or
contingent, and including any tax liabilities due or to become due) which under
generally accepted accounting principles would be required to be disclosed in
the Financial Statements and which are not fully reflected or provided for in
the Financial Statements. The Corporation does not know, and has no reason to
know, of any basis for the assertion against the Corporation or its
Subsidiaries of any material liabilities not adequately reflected or reserved
against in the Financial Statements.
3.15 Securities Filings. The Corporation has furnished Purchaser with all
documents and instruments filed by it and Decora Manufacturing since January 1,
1991 with the Securities and Exchange Commission, including, without
limitation, all Form 10-Q's, Form 10-K's, Form 8's and Form 8-K's
(collectively, the "Securities Filings"). As of the respective dates of the
<PAGE>
<PAGE> 6
Securities Filings, all statements made by the Corporation and Decora
Manufacturing in the Securities Filings were accurate, true and complete in all
material respects. Schedule 3.15 hereto lists the Securities Filings that were
not timely filed with the Securities and Exchange Commission since the Purchase
Agreement.
3.16 Representations in Operative Documents. All of the representations
and warranties made by the Corporation in the Operative Documents to which it
is a party are true and complete in all material respects.
3.17 Full Disclosure. This Agreement, the exhibits hereto, the Operative
Documents to which the Corporation is a party and all other materials that have
been furnished to Purchaser by the Corporation do not contain any untrue
statement of material fact and do not omit to state a material fact necessary
in order to make the statements contained herein or therein not misleading in
light of the circumstances under which they were made. To the best knowledge
of the Corporation, after such inquiry as it has deemed necessary, there is no
fact relating to the Corporation, its Subsidiaries or its or their assets,
properties, business, prospects, condition, affairs or operations that might
have a material adverse effect on the Corporation, its Subsidiaries or the
planned operations thereof which have not been disclosed to Purchaser in
writing by the Corporation.
ARTICLE IV
Conditions to Closing
by Purchaser
The obligation of Purchaser to amend and restate the Existing Note and the
Series A and Series B Warrants is subject to the fulfillment, to Purchaser's
satisfaction, of each of the following conditions at or prior to the Closing:
4.01 Performance. All covenants, agreements and conditions contained in
this Agreement, the Amended Note and the Warrants to be performed or complied
with by the Corporation on or prior to the Closing Date shall have been
performed or complied with by it in all respects.
4.02 Closing Certificate. At the Closing, the Corporation shall have
delivered to Purchaser a certificate, executed by the Chairman of the Board of
Directors or Chief Executive Officer of the Corporation, dated the Closing
Date, certifying to (a) the fulfillment of the conditions specified in this
Article IV, (b) that none of the representations and warranties made in Article
III hereof contain any untrue statement of material fact or omit to state a
material fact necessary in order to make the statements contained therein not
misleading in light of the circumstances under which they were made, and (c) to
such other matters as Purchaser shall have reasonably requested.
4.03 Legal Opinion. At the Closing, the Corporation shall have delivered
to Purchaser an opinion of Miller & Holguin, counsel to the Corporation, dated
the Closing Date, addressed to Purchaser and in the form of legal opinion
attached hereto as Exhibit 4.03.
<PAGE>
<PAGE> 7
4.04 Proceedings and Documents. As of the Closing Date, all corporate and
other proceedings in connection with the transactions contemplated by the
Operative Documents shall be satisfactory in form and substance to Purchaser
and his counsel, and Purchaser shall have received, at or prior to the Closing,
all such documents relating to such transactions as he shall have reasonably
requested.
4.05 Qualifications. On the Closing Date, all authorizations, approvals
or permits of, or filings with, any governmental authority, including state
securities or blue sky offices, that are required prior to the Closing in
connection with the issuance of the Amended Note or the Warrants, the issuance
of the shares of Common Stock to be issued upon execution of this Agreement by
Purchaser, payment of interest on the Amended Note, conversion of the Amended
Note and exercise of the Warrants shall have been duly obtained and shall be
effective on and as of the Closing Date.
4.06 Certificate of Incorporation. On the Closing Date, the Corporation
shall have delivered to Purchaser a copy of its certificate of incorporation,
including all amendments thereto through the Closing Date, that has been
certified by the Secretary of State for the State of Delaware.
4.07 Secretary's Certificate. At the Closing, the Corporation shall have
delivered to Purchaser copies of each of the following, in each case certified
as accurate, true and complete copies thereof as of the Closing Date by the
Corporation's Secretary:
(a) the by-laws of the Corporation, which shall be in a form
acceptable to Purchaser;
(b) resolutions of the Board of Directors of the Corporation,
authorizing and approving (1) the issuance and delivery of 309,400 shares of
Common Stock to Purchaser upon execution of this Agreement by Purchaser, (2)
the issuance and delivery of 472,689 shares of Common Stock to Purchaser as
prepaid interest due under the Amended Note, (3) the execution, issuance, sale,
delivery and performance of the Amended Note and the Warrants, (4) the
execution, delivery and performance of each of the Operative Documents to which
the Corporation is a party and the transactions contemplated thereby, and (5)
the reservation of an additional 817,647 shares of Common Stock for issuance
upon exercise of the Class C Warrant; and
(c) the signature(s) and incumbency of the officer(s) of the
Corporation authorized to execute and deliver the Operative Documents to which
the Corporation is a party.
4.08 Good Standing Certificates. At the Closing, the Corporation shall
have delivered to Purchaser good standing certificates, dated not more than ten
(10) days prior to the Closing Date, relating to the Corporation and Decora
Manufacturing from the Secretary of State for the state in which they were
incorporated.
<PAGE>
<PAGE> 8
4.09 Consents. At the Closing, the Corporation shall have delivered to
Purchaser copies of all consents and approvals of third parties required under
any licenses or agreements or otherwise in connection with the execution,
delivery or performance by the Corporation of the Operative Documents to which
it is a party.
4.10 Options and Other Rights. Schedule 4.10 hereto sets forth the names
of all other persons or entities having warrants, options, puts, calls,
registration rights, preemptive rights and/or other rights or obligations of
any kind to acquire, receive, convert or exchange shares of Common Stock or
other equity interests of the Corporation, including a brief description of
such rights and the exercise prices thereof.
4.11 Deliveries. At the Closing, the Corporation shall have delivered the
stock certificates for 309,400 shares and 472,689 shares, respectively, of
Common Stock, the Amended Note and the Warrants to Purchaser as provided in
Section 2.02 hereof.
4.12 Additional Documents. Purchaser shall have received such other
documents, instruments, approvals or opinions as Purchaser shall have
reasonably requested.
ARTICLE V
Covenants of the Corporation
The Corporation hereby covenants and agrees that:
5.01 Reservation of Shares. For so long as the Amended Note is
outstanding and the Warrants may be exercised, the Company shall at all times
have authorized, and reserved for the purpose of issue upon payment of interest
on the Amended Note, conversion of the Amended Note and exercise of the
Warrants, a sufficient number of shares of Common Stock to provide for payment
of interest on the Amended Note, the exercise of the conversion rights
represented by the Amended Note and the exercise of the rights represented by
the Warrants.
5.02 Compliance with Exchange Regulations. The Corporation shall take all
such action as may be necessary to assure that the Common Stock issuable upon
payment of interest on the Amended Note, conversion of the Amended Note and the
exercise of the Warrants may be so issued without violation of any applicable
law or regulation or of any requirements of any domestic securities exchange or
the National Association of Securities Dealers Automatic Quotation ("NASDAQ")
system upon which any capital stock of the Corporation may be listed, provided
Purchaser provides the Corporation with such information as the Corporation
shall reasonably request and that is necessary to comply with the requirements
of any such exchange or system.
5.03 Nomination of Director. At any meeting of the stockholders of the
Corporation at which directors are to be elected and for so long as the Amended
Note shall remain outstanding, the management of the Corporation shall, at the
<PAGE>
<PAGE> 9
written request of Purchaser, nominate Purchaser (or his nominee) to be elected
to the Board of Directors of the Corporation. If Purchaser chooses not to
exercise his right to be named or nominated, or to have his nominee named or
nominated, as a director at any time, Purchaser (or his nominee) shall have the
right to attend any and all meetings of the Corporation's Board of Directors as
an observer, and the Corporation shall provide Purchaser (or his nominee) with
the same advance notice of such meetings as is provided to the Corporation's
Board of Directors.
5.04 Directors' Expenses. Each of the Corporation's directors shall have
the right to be reimbursed for the reasonable expenses incurred by such
director in attending meetings of the Board of Directors of the Corporation and
for otherwise fulfilling his fiduciary obligations as a director of the
Corporation.
5.05 Directors' Meetings. The Corporation shall hold meetings of its
Board of Directors periodically but not less often than quarterly.
5.06 Director's Insurance. The Corporation shall use its best efforts to
procure from a financially reputable insurer a policy of director's insurance
with respect to Purchaser (or his nominee) in an amount and coverage
satisfactory to Purchaser. A certificate of insurance evidencing such
director's insurance shall be delivered by the Corporation to Purchaser. For
as long as Purchaser (or his nominee) serves as a director on the Board of
Directors of the Corporation, the Corporation shall maintain said policy of
director's insurance with respect to Purchaser (or his nominee) in an amount
and coverage satisfactory to Purchaser, and shall deliver to Purchaser
certificates of insurance evidencing the existence and timely renewal of said
policy of director's insurance.
5.07 Fees and Expenses. The Corporation agrees to bear all of its own
expenses in connection herewith, and shall also pay all expenses incurred by
Purchaser, including the legal fees and disbursements of Kohrman Jackson &
Krantz and of McCarthy, Lebit, Crystal & Haiman, counsel to Purchaser, in
connection with the transactions contemplated hereby, including, without
limitation, all expenses incurred in connection with (a) the preparation,
negotiation, closing under, amendment, waiver, administration or enforcement
of, or the preservation of any rights under any of the Operative Documents or
under the Corporation's certificate of incorporation or by-laws, (b) any stamp
and other taxes payable with respect to this Agreement and the shares of Common
Stock issuable upon execution of this Agreement by Purchaser, payment of
interest on the Amended Note, conversion of the Amended Note and exercise of
the Warrants, and (c) any filing with any governmental agency with respect to
Purchaser's purchase of the Amended Note, the Warrants or the shares of Common
Stock issuable upon execution of this Agreement by Purchaser, payment of
interest on the Amended Note, conversion of the Amended Note and exercise of
the Warrants; provided, however, that the Corporation shall have no obligation
to pay any broker's commissions upon the sale by Purchaser of any shares of
Common Stock issued to him upon execution by him of this Agreement, payment of
interest on the Amended Note, conversion of the Amended Note or exercise of the
Warrants.
<PAGE>
<PAGE> 10
5.08 Indemnification.
(a) The Corporation shall indemnify, defend and hold Purchaser
harmless from and against and in respect of any and all claims, demands,
losses, costs, expenses, obligations, liabilities, damages, recoveries and
deficiencies, including, without limitation, interest, penalties, court costs
and attorneys' fees, that Purchaser shall incur or suffer, which arise, result
from, or relate to any breach of, or failure by the Corporation to perform, any
of its representations, warranties, covenants or agreements in any of the
Operative Documents to which it is a party or in any other agreement or any
schedule, certificate, exhibit or instrument furnished or to be furnished by
the Corporation hereunder or thereunder or in the certificate of incorporation
of the Corporation.
(b) If any indemnifiable claim by a third party is made against
Purchaser, Purchaser shall provide written notice to the Corporation of such
claim. By delivering written notice to Purchaser within fifteen days after
receipt of Purchaser's notice, the Corporation may, or upon written request of
Purchaser shall, assume the defense of such claim at its sole expense through
counsel satisfactory to Purchaser, provided that (1) the Corporation shall not
permit any lien, encumbrance or other adverse charge upon any asset of
Purchaser, (2) the Corporation shall permit Purchaser to participate in such
settlement or defense through counsel selected by Purchaser at Purchaser's
expense, and (3) the Corporation shall agree to promptly reimburse Purchaser
for the full amount of his liability to the third-party claimant. If the
Corporation shall not have employed counsel to defend such claim or if
Purchaser shall have reasonably concluded that the position of Purchaser and
the Corporation may be in conflict (in which case the Corporation shall not
have the right to direct the defense of any such claim on behalf of Purchaser),
legal and other expenses incurred by Purchaser shall be borne by the
Corporation. Notwithstanding the foregoing, Purchaser shall have the right to
pay or settle any such claim provided in such event it shall waive its right to
indemnity therefor by the Corporation.
5.09 Certain Restrictions and Limitations. For so long as the Amended
Note remains outstanding, the Corporation shall not, without the approval of
Purchaser:
(a) permit any of its Subsidiaries to amend, its certificate or
articles of incorporation or by-laws;
(b) permit any of its Subsidiaries to increase or decrease, the
total number of its authorized shares of capital stock or any class or series;
(c) permit its Subsidiaries to declare or pay, any cash or other
dividend or make any other distribution of any kind on their capital stock
other than dividends and distributions from any of the Subsidiaries to the
Corporation or to any other Subsidiaries;
(d) permit any of its Subsidiaries to enter into, any agreement with
respect to any merger or consolidation (other than a merger into or
<PAGE>
<PAGE> 11
consolidation with the Corporation or any of its wholly-owned Subsidiaries) or
transfer, or permit any of its Subsidiaries to transfer, whether by sale, lease
or other disposition in one or more transactions, an amount greater than ten
percent (10%) of the Corporation's or any of its Subsidiaries' assets;
provided, however, that this limitation shall not apply to (1) transfers to the
Corporation or any of the Corporation's wholly-owned Subsidiaries, or (2)
dispositions of obsolete equipment;
(e) permit any of its Subsidiaries to enter into or permit to exist,
any agreement or undertaking (other than this Agreement) which prohibits,
restricts or limits the ability of any of its Subsidiaries to pay dividends or
distributions to the Corporation, or otherwise to transfer assets or engage in
transactions with the Corporation; or
(f) permit any of its Subsidiaries to issue or sell or to obligate
such Subsidiary to issue or sell any shares of its capital stock (including any
warrants, rights or options to purchase or otherwise acquire shares of such
capital stock or other securities exercisable or exchangeable for or
convertible into shares of such capital stock).
ARTICLE VI
Events of Default
6.01 Events of Default. If any of the following events (each is herein
referred to as an "Event of Default") shall occur:
(a) default shall occur in the performance of or compliance with any
covenant contained in Section 5.09 hereof;
(b) material default shall occur in the performance of or compliance
with any other covenant contained herein which shall continue uncured for more
than ten days after the occurrence of such default;
(c) if any representation or warranty to Purchaser made in writing
by the Corporation in this Agreement or in any other Operative Document, or in
connection with the transactions contemplated hereby or thereby, shall prove to
have been false or inaccurate in any material respect on the date as of which
made;
(d) the Corporation fails to execute and deliver the Amended Note to
Purchaser in the principal amount required by Section 1.02 hereof and at the
time required by Section 2.02 hereof;
(e) all or any part of the principal or interest due under the
Amended Note is not paid when and as the same shall become due and payable,
whether at the maturity thereof, by acceleration, by notice of prepayment or
otherwise;
(f) any default in excess of $250,000 shall occur in the making of
the payment of the principal of or interest on any other indebtedness of the
<PAGE>
<PAGE> 12
Corporation or any of its Subsidiaries for borrowed money, as and when the same
shall become due and payable by the lapse of time, by declaration, by call for
redemption or otherwise;
(g) default or the happening of any event shall occur under any
indenture, agreement or other instrument under which any indebtedness of the
Corporation or any of its Subsidiaries for borrowed money is or may be issued,
and such default or event shall continue for a period of time sufficient to
permit the acceleration of the maturity of any indebtedness of the Corporation
or any of its Subsidiaries outstanding thereunder;
(h) a receiver, conservator, custodian, liquidator or trustee of the
Corporation or any of its Subsidiaries or of all or any of the property of any
of them is appointed by court order and such order remains in effect for more
than sixty (60) days; or an order for relief is entered under the federal
bankruptcy laws with respect to the Corporation or any of its Subsidiaries; or
any of its material property is sequestered by court order and such order
remains in effect for more than sixty (60) days; or a petition is filed against
the Corporation or any of its Subsidiaries under the bankruptcy,
reorganization, arrangement, insolvency, readjustment of debt, dissolution or
liquidation law of any jurisdiction, whether now or hereafter in effect, and is
not dismissed within sixty (60) days after such filing;
(i) the Corporation or any of its Subsidiaries files a petition in
voluntary bankruptcy or seeking relief under any provision of any bankruptcy,
reorganization, arrangement, insolvency, readjustment of debt, dissolution or
liquidation law of any jurisdiction, whether now or hereafter in effect, or
consents to the filing of any petition against it under any such law;
(j) the Corporation or any of its Subsidiaries makes an assignment
for the benefit of its creditors, or admits in writing its inability to pay, or
in fact does not pay, its debts generally as they become due, or consents to
the appointment of a receiver, conservator, custodian, liquidator or trustee of
the Corporation or any of its Subsidiaries, or of all or any part of the
property of any of them;
(k) final judgment for the payment of money in excess of $250,000
shall be rendered by a court of record against the Corporation or any of its
Subsidiaries, and the Corporation or such Subsidiary shall not (1) discharge
the same (by insurance or otherwise) or provide for its discharge in accordance
with its terms, or (2) procure a stay of execution thereof within sixty (60)
days from the date of entry thereof and within said period of sixty (60) days,
or such longer period during which execution of such judgment shall have been
stayed, appeal therefrom and cause the execution thereof to be stayed during
such appeal;
(l) a breach of any term or provision of any of the Warrants; or
(m) the Corporation is delisted or otherwise removed from the NASDAQ
system and is not on the same or next business day listed on any national
securities exchange; then, when any Event of Default described in clause (c),
<PAGE>
<PAGE> 13
(d), (g), (k) or (l) of this Section 6.01 has occurred and shall be
continuing, the Amended Note shall, upon written or facsimile notice from
Purchaser, forthwith be due and payable, if not already due and payable; and
when any Event of Default described in clause (a), (b), (e), (f), (h), (i), (j)
or (m) of this Section 6.01 has occurred, then, at the option of Purchaser, the
principal of the Amended Note shall be immediately due and payable, by
acceleration, without presentment, demand or notice of any kind, upon the
occurrence thereof. If any principal or installment of interest is not paid in
full on the due date thereof (whether by maturity or acceleration or
otherwise), then the outstanding principal balance of the Amended Note and any
overdue installment of interest thereon (to the extent permitted by applicable
law) shall bear additional interest from the due date of such payment, or from
and after an Event of Default, at a rate equal to the lesser of (1) the highest
rate allowed by applicable law, or (2) sixteen percent (16%) per annum (the
"Default Rate") until the amount due is paid. If payment of the Amended Note
is accelerated, then the outstanding principal balance thereof shall bear
interest at the Default Rate from and after the Event of Default and, at the
option of Purchaser, payment of interest shall be made in cash. The
Corporation agrees to reimburse Purchaser for all reasonable out-of-pocket
costs and expenses incurred by him in any effort to collect the Amended Note,
whether or not suit is filed, including reasonable compensation to Purchaser's
attorneys for services rendered in connection therewith, and pay interest on
such costs and expenses to the extent not paid when demanded at the Default
Rate.
6.02 Remedies on Default.
(a) If an Event of Default shall have occurred pursuant to Section
6.01, Purchaser shall be entitled, in addition to the rights specified in
Section 6.01, to the rights set forth in the Amended Note and the Warrants and,
in addition, may proceed to protect and enforce any or all other rights, powers
and remedies of such holders by an action at law, suit in equity or other
appropriate proceeding, whether for the specific performance of any covenant
contained herein or in the Amended Note and the Warrants or for an injunction
against a violation of any of the terms hereof or thereof, or in aid of the
exercise of any right, power or remedy granted hereby or thereby or available
at law, in equity, by statute or otherwise.
(b) If any holder of any shares of capital stock or any indebtedness
of the Corporation for borrowed money shall serve any notice or demand or take
any other action in respect of a claimed default, the Corporation shall
forthwith give written notice thereof to Purchaser, describing the notice,
demand or action and the nature of the claimed default.
(c) No right, power or remedy conferred hereby or by ownership of
the Amended Note, or now or hereafter available at law, in equity, by statute
or otherwise shall be exclusive of any other right, power or remedy referred to
herein or therein or now or hereafter available at law, in equity, by statute
or otherwise.
<PAGE>
<PAGE> 14
ARTICLE VII
Miscellaneous
7.01 Consent to Amendments. The provisions of this Agreement may be
amended only in writing by mutual agreement of the Corporation and Purchaser.
No course of dealing between the Corporation and Purchaser or any delay in
exercising any rights hereunder or under the Amended Note or Existing Note
shall operate as a waiver of any rights of Purchaser.
7.02 Survival of Representations and Warranties. All representations and
warranties contained herein or made in writing by any party in connection
herewith shall survive the execution and delivery of this Agreement, the
consummation of the Closing and any investigation made at any time by or on
behalf of Purchaser.
7.03 Successors. Except as otherwise expressly provided herein, all
covenants and agreements contained in this Agreement by or on behalf of any of
the parties hereto shall bind and inure to the benefit of the respective heirs,
executors, personal representatives, successors and assigns of the parties
hereto, whether so expressed or not. In addition, and whether or not any
express assignment has been made, the provisions of this Agreement which are
for the benefit of Purchaser are also for the benefit of, and enforceable by,
any subsequent holders of any portion of the Amended Note or the Warrants
except any subsequent holder who acquires any such security in a registered
public offering or in a sale to the public under Rule 144.
7.04 Severability. Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement is held to be prohibited
by or invalid under applicable law, such provision shall be ineffective only to
the extent of such prohibition or invalidity, without invalidating the
remainder of this Agreement.
7.05 Descriptive Headings. The descriptive headings of this Agreement are
inserted for convenience of reference only and do not constitute a part of this
Agreement.
7.06 Notices. Any notices required, desired or permitted to be given
hereunder, shall be delivered personally, sent by overnight courier or mailed,
registered or certified mail, return receipt requested, to the following
addresses (or to such other address as each party may specify in a notice given
hereunder) and shall be deemed to have been received on the day of personal
delivery, one business day after delivery to the overnight courier service or
three business days after such mailing:
If to Purchaser:
Robert W. Johnson IV
The Johnson Co., Inc.
630 Fifth Avenue, Suite 1510
New York, New York 10111
<PAGE>
<PAGE> 15
with copies to:
Larry Crystal, Esq.
McCarthy, Lebit, Crystal & Haiman
1800 Midland Building
101 Prospect Avenue West
Cleveland, Ohio 44115
and
Marc C. Krantz, Esq.
Kohrman Jackson & Krantz
One Cleveland Center, 20th Floor
Cleveland, Ohio 44114
If to the Corporation:
Nathan Hevrony
Decora Industries, Inc.
1 Mill Street
Fort Edward, New York 12828
with a copy to:
Dale S. Miller, Esq.
Miller & Holguin
1801 Century Park East
Seventh Floor
Los Angeles, California 90067
7.07 Governing Law. The validity, meaning and effect of this Agreement
shall be determined in accordance with the laws of the State of New York
applicable to contracts made and to be performed in that State.
7.08 Purchaser's Investment Representations. Purchaser hereby represents
and warrants to the Corporation that:
(a) he is acquiring the 309,400 shares of Common Stock to be issued
to him upon his execution of this Agreement, the 472,689 shares of Common Stock
to be issued to him as prepaid interest on the Amended Note, and the Series C
Warrant for his own account and not with a view to reselling or distributing
such securities in any transaction which would constitute a "distribution"
within the meaning of the Securities Act;
(b) he has such knowledge and experience in financial and business
matters that he is capable of evaluating the merits and risks of his investment
in said 782,089 shares of Common Stock and the Series C Warrant;
(c) he is able to bear the economic risks of an investment in said
782,089 shares of Common Stock and the Series C Warrant, including, without
<PAGE>
<PAGE> 16
limiting the generality of the foregoing, the risk of losing part or all of his
investment in said 782,089 shares of Common Stock and the Series C Warrant;
(d) he has had the opportunity to ask questions of, and receive
answers from, the Corporation concerning the terms and conditions of the
offering of said 782,089 shares of Common Stock and the Series C Warrant and to
obtain additional information about the Corporation;
(e) he is not an entity formed solely to make this investment;
(f) his execution, delivery and performance of this Agreement will
not breach the provisions of any agreement to which he is a party;
(g) he is an "accredited investor" as defined in Rule 501
promulgated under the Securities Act;
(h) he will transfer the securities acquired hereunder in accordance
with the Securities Act;
(i) the offer to sell said 782,089 shares of Common Stock and the
Series C Warrant was directly communicated to him in such a manner that he was
able to ask questions of and receive answers concerning the terms of this
transaction, and that at no time was he presented with or solicited by any
leaflet, public or promotional meeting, newspaper or magazine article, radio or
television advertisement or any other form of general advertising otherwise
than in connection and concurrently with such communicated offer;
(j) he has been advised that said 782,089 shares of Common Stock and
the Series C Warrant and the shares of Common Stock to be issued upon payment
of interest on and/or conversion of the Amended Note and/or exercise of the
Warrants are, or when issued will be, "restricted securities" as that term is
defined in Rule 144 promulgated under the Act; and
(k) all representations made by him in this Section 7.08 are
accurate, true and complete in all material respects as of the date hereof.
7.09 Confidentiality. The Corporation shall not, without Purchaser's
consent or unless required by law, disclose any of the information supplied by
Purchaser to the Corporation in connection with the transactions contemplated
by any of the Operative Documents to any person or entity other than the
directors and officers of, and counsel and accountants for, the Corporation who
need to know such information in order to consummate said transactions.
7.10 Exhibits and Schedules. All exhibits and schedules hereto and the
schedules and other documents to be delivered to Purchaser pursuant hereto are
an integral part of this Agreement.
7.11 Delays or Omissions. No delay or omission to exercise any right,
power or remedy accruing to Purchaser, upon any breach or default of the
Corporation under any of the Operative Documents, shall impair any such right,
power or remedy of Purchaser or shall be construed to be a waiver of any such
<PAGE>
<PAGE> 17
breach or default, or an acquiescence therein, or of or in any similar breach
or default thereafter occurring; and any waiver of any single breach or default
shall not be deemed a waiver of any other breach or default theretofore or
thereafter occurring. Any waiver, permit, consent or approval of any kind or
character on the part of any such holder of any provisions or conditions of the
Operative Documents must be made in writing and shall be effective only to the
extent specifically set forth in such writing. All remedies, under either the
Operative Documents or by law or otherwise afforded to Purchaser, shall be
cumulative and not alternative.
7.12 Execution in Counterparts. This Agreement may be executed in any
number of counterparts, each of which when so executed and delivered shall be
deemed an original, and such counterparts together shall constitute one
instrument. Each party shall receive a duplicate original of the counterpart
copy or copies executed by it and the other party.
7.13 Entire Agreement. This Agreement, together with the exhibits and
schedules hereto and the schedules and other documents to be delivered pursuant
hereto, and the other Operative Documents constitute the entire agreement of
the parties concerning the matters referred to herein and therein, and
supersede all prior and contemporaneous agreements and understandings.
<PAGE>
<PAGE> 18
IN WITNESS WHEREOF, the parties hereto have executed this Agreement
effective the date first set forth above.
DECORA INDUSTRIES, INC.
By: /s/Timothy Burditt
-----------------------------
Its:EVP Administration & Finance
-----------------------------
--------------------
Robert W. Johnson IV
DECORA INDUSTRIES, INC.
By:
-----------------------------
Its:
-----------------------------
/s/Robert W. Johnson IV
-----------------------
Robert W. Johnson IV
